Another important message delivered by our cohort study is to consider a mitochondrial etiology in parkinsonism or other movement disorders, especially when other mitochondrial “red flags” are associated; in these conditions, we recommend to screen patients for variants in mitochondrial nuclear genes (mainly TWNK, OPA1, POLG1 and SPG7). Here, OPA1 is linked to movement disorder.